[The incidence and risk factors of late-onset non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.].

Tao Wu(The Graduate Center, CUNY), Jing Sun(Chongqing Academy of Animal Science), Qifa Liu(University of Science and Technology of China), Zhiping Fan(Nanchang University), Yu Zhang(Wannan Medical College), Dan Xu
PubMed
April 1, 2010
Cited by 1

Related Papers

Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
|Frontiers in Immunology|2017|209